Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
888 studies found for:    il-13
Show Display Options
Rank Status Study
21 Completed A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Intervention: Drug: Ciclesonide nasal spray, 50 μg per actuation.
22 Completed CARATKids: Italian Validation of Asthma and Allergic Rhinitis Control Test in Children
Conditions: Allergic Rhinitis;   Asthma
Intervention: Other: CARATKids Questionnaire
23 Completed IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: Surgery for placement;   Procedure: Radiation therapy;   Drug: Temozolomide with radiation therapy
24 Completed The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: IL13-PE38QQR;   Procedure: surgery and catheter placement (2 procedures);   Drug: prolifespan 20 with carmustine implant (GLIADEL® Wafer);   Procedure: surgery and wafer placement (1 procedure)
25 Recruiting The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis
Condition: Other Allergic Rhinitis
Intervention: Procedure: nasal allergen provocation test
26 Completed SD, IL-13 Production Rate in IPF
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: QAX576
27 Enrolling by invitation A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Azelastine HCl and Fluticasone Propionate Nasal Spray, 137 µg/50 µg per spray;   Drug: Dymista™ Nasal Spray;   Drug: Placebo
28 Unknown  Effect of Montelukast on Basophils, In-vitro
Conditions: Allergic Asthma;   Allergic Rhinitis
Intervention:
29 Completed Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine
Condition: Allergic Rhinitis
Interventions: Drug: Bilastine;   Drug: Loratadine
30 Recruiting Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Biological: ILIT with extract of causal allergen;   Biological: ILIT with normal saline;   Drug: Rescue medication for allergic rhinitis
31 Completed A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis
Conditions: Allergic Rhinitis;   Rhinitis, Allergic, Seasonal
Interventions: Drug: GSK256066;   Drug: azelastine hydrochloride
32 Terminated Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
Conditions: Rhinitis, Allergic, Seasonal;   Seasonal Allergic Rhinitis
Intervention: Drug: Fluticasone furoate nasal spray
33 Completed A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults
Condition: Allergic Rhinitis
Interventions: Drug: JNJ-17166864;   Drug: Placebo
34 Completed Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
Condition: Allergic Rhinitis
Intervention:
35 Completed Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms
Condition: Seasonal Allergic Rhinitis
Interventions: Dietary Supplement: Lectranal;   Dietary Supplement: placebo
36 Terminated Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients
Condition: Allergic Rhinitis
Interventions: Drug: HollisterStier;   Drug: Normal saline
37 Not yet recruiting Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
38 Not yet recruiting Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
39 Completed An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever
Condition: Allergic Rhinitis
Interventions: Drug: QAX576;   Drug: Placebo
40 Completed Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
Condition: Allergic Rhinitis
Interventions: Other: healthy controls;   Other: AR patients without medication;   Other: AR patients with use of nasal corticoid spray

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.